Cytokinetics Inc vs Unilever plc — how do they compare? Cytokinetics Inc trades at $77.39 (market cap $10.78B), while Unilever plc trades at $61.88 (market cap $134.76B). The key difference: Unilever plc is far larger — about 12.5× Cytokinetics Inc's market cap, and Unilever plc pays a 3.63% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | UL | |
|---|---|---|
Market Cap | $10.78B | $134.76B |
Sector | Technology | Consumer Staples |
52-Week High | $87.26 | $74.59 |
52-Week Low | $34.31 | $55.05 |
Enterprise Value | $10.88B | $160.58B |
Dividend Yield | — | 3.63% |
Signals from Pluang's Aura AI — not financial advice
Cytokinetics (CYTK) trades at $76.76, down 5.67% today, with a bearish technical signal and negative profitability metrics. Recent Q2 2026 earnings beat EPS estimates but missed on revenue, while the company's drug Myqorzo shows strong commercial uptake and regulatory approvals in the UK. Cash flow remains negative from operations, offset by financing activities.
The outlook is mixed: strong analyst buy ratings (97%) and a $111.14 price target suggest upside, but high cash burn, competitive pressures, and lack of profitability pose significant risks. Investment appeal hinges on successful drug commercialization and path to profitability.
No Aura AI signal available yet.
Trailing returns across standard periods
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →Unilever is a diversified personal product (42% of 2021 sales by value), home care (20%), and packaged food (38%) company. Its brands include Knorr soups and sauces, Hellmann's mayonnaise, Lipton teas, Axe and Dove skin products, and the TRESemme haircare brand. The firm has been acquisitive in recent years
Read more on UL →